The albuminuria‐lowering response to dapagliflozin is variable and reproducible among individual patients
Sign Up to like & getrecommendations! Published in 2017 at "Diabetes"
DOI: 10.1111/dom.12936
Abstract: Albuminuria reduction is essential for renal and cardiovascular protection. We characterized the efficacy of dapagliflozin, a sodium‐glucose co‐transporter 2 inhibitor, on albuminuria. Secondly, we assessed whether the albuminuria‐lowering effect varies among patients, and whether this… read more here.
Keywords: response dapagliflozin; lowering response; albuminuria lowering; dapagliflozin variable ... See more keywords